Opgenra
Opgenra Uses, Dosage, Side Effects, Food Interaction and all others data.
A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Opgenra is an ingredient in the EMA-withdrawn product Osigraft.
| Trade Name | Opgenra |
| Generic | Eptotermin alfa |
| Eptotermin alfa Other Names | BMP-7, Bone morphogenetic protein 7, Eptotermin alfa, Eptotermina alfa, HBMP7, HrBMP-7, Human recombinant bone morphogenetic protein 7, OP-1, Osteogenic protein 1, RH-polypeptide-52 |
| Type | |
| Groups | Approved, Investigational, Withdrawn |
| Therapeutic Class | |
| Manufacturer | Howmedica International S De R L, Olympus |
| Available Country | France, Netherlands, Portugal, Spain |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Opgenra
